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Synopisis Bullet Points: 
 
Mapping of the relationship between chromatin signatures and regions occupied by Su(H) 
identifies preferred binding context which can be conferred by cooperating transcription factors. 
 
>91% of Su(H) motifs are likely to be masked from binding due to the chromatin environment, but 
paradoxically only 7-10% of CSL motifs within favourable chromatin are bound. 
 
Rapid changes in acetylation of H3K56 occur at regulated-enhancers following Notch activation 
while many other histone modifications are unchanged 
 
H3K56ac extends over large regions, requires the histone acetyl-transferase CBP and precedes 
changes in transcription 
 
Rapid changes in H3K56 acetylation are a conserved indicator of enhancer activation 
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ABSTRACT 
The conserved Notch pathway functions in diverse developmental and disease-related processes, 
requiring mechanisms to ensure appropriate target-selection and gene activation in each context. 
To investigate the influence of chromatin organization and dynamics on the response to Notch 
signaling, we partitioned Drosophila chromatin using histone modifications and established the 
preferred chromatin conditions for binding of Su(H), the Notch pathway transcription factor. By 
manipulating activity of a co-operating factor, Lozenge/Runx, we showed that it can help facilitate 
these conditions. While many histone modifications were unchanged by Su(H) binding or Notch 
activation, we detected rapid changes in acetylation of H3K56 at Notch regulated-enhancers. This 
modification extended over large regions, required the histone acetyl-transferase CBP and was 
independent of transcription. Such rapid changes in H3K56 acetylation appear to be a conserved 
indicator of enhancer activation as they also occurred at the mammalian Notch-regulated Hey1 
gene and at Drosophila ecdysone-regulated genes. This intriguing example of a core histone 
modification increasing over short timescales may therefore underpin changes in chromatin 
accessibility needed to promote transcription following signaling activation. 
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INTRODUCTION 
Notch is the receptor in a highly conserved signalling pathway that is of major importance in many 
developmental and disease contexts (Bray, 2006; Kopan & Ilagan, 2009; Louvi & Artavanis-
Tsakonas, 2012; Miele et al, 2006). Despite a relatively simple transduction pathway, the outcomes 
of Notch activation are diverse and such diversity is essential for animal development. It is also of 
considerable significance in cancers, since Notch activity can promote tumorigenesis in some 
tissues and suppress it in others (Miele et al, 2006; Ntziachristos et al, 2014; Radtke & Raj, 2003; 
Roy et al, 2007). However, the mechanisms underlying pathway specificity remain poorly 
understood. Likewise, little is known about the genomic changes that occur during the transition of 
Notch-regulated genes to activated states.   
 
Although its effects are pleiotropic, Notch acts primarily through a single core transcription factor 
(Bray, 2006; Kopan & Ilagan, 2009) which is known generally as CSL (CBF1, Suppressor of 
Hairless, Lag1) and specifically as Suppressor of Hairless [Su(H)] in Drosophila. When Notch 
receptors are activated by ligands carried on an adjacent cell, they become susceptible to 
cleavage by Adam 10 and γ-secretase. Receptor cleavage results in the release of an intracellular 
fragment, NICD, which forms a complex with CSL and the co-activator Mastermind (Mam) (Kopan 
& Ilagan, 2009; Kovall & Blacklow, 2010). This complex recruits histone acetylases (HAT) of the 
p300 family and up-regulates expression of genes to which it is recruited (Borggrefe & Oswald, 
2009), the best characterized being genes of the HES/HEY family (Bray & Bernard, 2010). These 
include the Drosophila Enhancer of split Complex [E(spl)-C], where twelve Notch responsive genes 
are clustered in a 60kb region. 
 
Genome-wide studies in Drosophila, mouse and human cells have shown that CSL is bound at 
different target sites depending on the cell type (e.g.(Jin et al, 2013; Krejci et al, 2009; Terriente-
Felix et al, 2013; Wang et al, 2014; Wang et al, 2012). Although it is evident that tissue specific 
factors help to mediate this specificity, it is not yet clear how they do so. For example, in Drosophila 
blood cells, the Runx family transcription factor Lozenge (Lz) is necessary for activity of Notch-
regulated enhancers and it helps promote binding of Su(H) to its targets sites via an unknown 
mechanism (Terriente-Felix et al, 2013). Likewise, in mammalian T-lymphoblastic leukemia cells 
CSL-bound enhancers frequently overlapped with RUNX1 binding motifs suggesting that similar 
mechanisms could confer specificity in these cells (Wang et al, 2014). As there is no evidence for 
direct interactions between CSL and Lz/Runx, it seems likely that recruitment involves indirect 
effects. 
 
Unlike transcription factors, such as FoxA, which are capable of binding to their target motifs even 
when wrapped around the histone core (Sekiya et al, 2009; Zaret & Carroll, 2011), CSL appears to 
preferentially bind to motifs located outside the nucleosome (Lake et al, 2014). Thus one way that 
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variations in CSL binding could be specified is through changes in the organization of the 
chromatin, directed by cell-specific pioneer transcription factors. It is evident that the structure of 
chromatin differs considerably in a manner that correlates with different histone modifications and 
with the presence of architectural proteins, such as HP1 (de Wit & van Steensel, 2009; Kouzarides, 
2007). For example, specific histone tail modifications, H3K4 mono-methylation (H3K4me1) and 
H3K27 acetylation (H3K27ac), are associated with active enhancers (Calo & Wysocka, 2013; 
Creyghton et al, 2010; Smith & Shilatifard, 2014). Such modifications can be recognized by so-
called Readers, which are often constituents of complexes that alter the organization or sub-
nuclear localization of the modified locus (Lalonde et al, 2014; Swygert & Peterson, 2014). For 
example, several chromatin-remodelling complexes contain proteins with bromodomains that 
recognize acetylated histone motifs (Filippakopoulos & Knapp, 2014; Taverna et al, 2007). 
Additionally, modifications to the histone core, such as H3K56 acteylation (H3K56ac), have the 
potential to directly alter DNA interactions (Neumann et al, 2009; Simon et al, 2011). Thus it is 
possible that particular combinations of histone modifications, engineered by tissue-specific 
regulators, could be a pre-requisite for CSL recruitment at Notch-regulated enhancers.  
 
Changes to chromatin modifications and conformation may also be important for the induction of 
target gene expression following Notch activation. While there is a low level of CSL binding at 
Notch-regulated enhancers prior to pathway activation, its recruitment is greatly enhanced in the 
presence of NICD (Castel et al, 2013; Housden et al, 2013; Krejci & Bray, 2007; Wang et al, 2014). 
Additional localized chromatin alterations may contribute to enhanced stability of the CSL/NICD 
complex on DNA. Furthermore, transitions in enhancer activity are also associated with changes in 
histone modifications. For example, the presence of H3K27ac at enhancers is thought to 
distinguish active from primed enhancers (Calo & Wysocka, 2013; Smith & Shilatifard, 2014) and 
has been detected following changes to Notch activity in myogenic and leukemic cells (Castel et al, 
2013; Wang et al, 2014). Exploring the mechanisms associated with Notch-induced enhancer 
activation is important in the context of emerging therapeutic strategies targeting chromatin 
regulators (Helin & Dhanak, 2013). 
 
In order to investigate whether chromatin organization can explain the cell-type specificity of Su(H) 
recruitment and how it relates to Notch regulated enhancer activation, we took advantage of 
detailed profiling of histone modifications in Drosophila cells performed by modENCODE. 
Combining our new data on H3K56ac with modENCODE data on 23 different histone 
characteristics and DNAse I hypersensitivity (Kharchenko et al, 2011), we derived models of the 
chromatin signatures in two different cell-types and then related this to Su(H) binding profiles. We 
found that Su(H) occupancy is predominantly associated with two specific chromatin signatures, 
and that the co-operating Lz/Runx transcription factor can help to confer characteristics of the 
preferred state. Su(H) and NICD also shape the chromatin at bound regions, in particular, 
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H3K56ac is strongly increased across regulated loci following Notch activation. This modification to 
the H3 core appears to be dependent on CBP and occurs independently of transcription elongation 
from the transcribed loci. Thought to promote local DNA breathing (Neumann et al, 2009), we find 
that H3K56ac correlates with elevated transcription from the enhancer regions (intergenic RNAs). 
Analysis of H3K56ac after ecdysone stimulation indicate that changes to this histone modification 
are more generally applicable in Drosophila and our observation of similar Notch signalling 
dependent changes at the mouse Hey1 enhancer, indicate that this is a conserved mechanism.  
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RESULTS 
Relationship between chromatin states and Su(H) occupancy  
Our initial goal was to determine which aspects of the chromatin environment, as defined by the 
presence or absence of particular histone modifications, could contribute to Su(H) binding and 
hence to the cell specificity of Notch responsive genes. To achieve this we generated a map of 
chromatin states within Drosophila BG3 (CNS) and Kc167 (blood) cells, and also determined the 
positions where Su(H) was bound. Since chromatin states have not previously been derived for 
these cell types we utilised an adaptation of a previously described Hidden Markov model (HMM) 
approach (Kharchenko et al, 2011) to generate genome-wide chromatin maps for the two cell 
types.  
 
We used the available datasets for 23 histone modifications, DNase I hypersensitivity maps and 
new genome-wide H3K56ac datasets generated as part of this study (Fig. 1A, E1A). Although 
H3K56ac overlaps with key regulators of pluripotency in human cells (Xie et al, 2009), this 
modification has not been profiled in many transcriptional contexts nor included in previous 
chromatin models. In Drosophila cells we found that H3K56ac was highly enriched at enhancers 
and around active transcription start-sites (TSS), correlating most strongly with H3K9ac and 
H3K4me2 (Fig. E2). H3K56ac also showed strong relationships with the H3K27ac and H3K4me1 
modifications known to be associated with enhancers (Fig. E2). A single data matrix was therefore 
created, combining the H3K56ac and modENCODE ChIP data with DNase I accessibility, and then 
tied parameterisation was used to identify the maximum number of unique chromatin signatures 
that could be inferred before splitting a signature into two similar ones (see Extended view for more 
details). This strategy was used to minimize the risk of over-fitting, one potential drawback of this 
type of maximum likelihood HMM. The fact that we recovered similar signatures to those obtained 
through a more complex Bayesian model (Fig. E1C) indicates the success of the strategy, as did 
with results from a leave one out analysis, which demonstrates the robustness of the signatures 
(Fig. E1F). The latter also highlights that some histone modifications have more dominant roles, 
while others are less discriminatory for the chromatin signatures. 
 
The 11 chromatin signatures we recovered showed extensive similarities with the chromatin states 
generated through a comparative analysis of metazoan chromatin (Fig. 1B and Fig. E1A-C; Ho et 
al, 2014). Despite differences in the approaches used, both identified similar types of regulatory 
chromatin, indicating that our simple method adequately captured the most frequent chromatin 
patterns. In particular, the active regulatory chromatin was partitioned into three types, which we 
refer to as enhancer (Enh; red), competent (Comp; green) and active intron (aIntr; purple) (Fig. 
E1A-E). Enh encompasses canonical modifications H3K4me1 and H3K27ac associated with 
enhancers and is also enriched for H3K56ac. In BG3 cells it also corresponds to regions with 
regulatory activity, as identified by functional methods for discovering enhancers in BG3 cells 
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(STARR-seq, Fig. E1A; Yanez-Cuna et al, 2014). Competent chromatin is marked by H3K4me1 
but has low levels of the other enhancer modifications and frequently appears to represent 
enhancer regions that are not yet fully active, as supported by our subsequent experiments. The 
third regulatory chromatin, active intron, differs in its enrichment for H2B ubiquitination, one of the 
modifications important in differentiating these three types (Fig. E1F).  
 
Having generated chromatin signature maps for BG3 and Kc cells we then determined the 
genome-wide profile of Su(H)-binding in the two cell-types to determine the relationship between 
bound regions and chromatin states (e.g. see E(spl)-C, Fig. 1A). A comparable number of regions 
were bound by Su(H) in the two cell lines, of which 25-30% were bound in both cell types (Fig. 
1C). Although relatively few peaks were identified in comparison to some other DNA binding 
proteins, the low number is consistent with the observation that CSL/Su(H) exhibits low occupancy 
in the absence of NICD at many Notch-regulated enhancers (Castel et al, 2013; Housden et al, 
2013; Krejci & Bray, 2007; Wang et al, 2014) and the data were consistent across replicates (Fig 
E3A). In both cell types the mean peak width was similar (circa 500bp; Fig. E3B), but occasionally, 
in regions of high occupancy at the E(spl) locus, these peaks overlapped to generate a super-peak 
of several kb. By far the majority of the bound regions were located within Enh chromatin (red, Fig. 
1D, E). The remainder were predominantly in another active region with TSS features (aTSS, 
orange; Fig. 1D, E) with a small proportion in Comp or Polycomb domains. The few peaks that 
mapped to other types of chromatin may reflect unusual binding events but could also arise from 
false positives in the chromatin assignments or in the ChIP data. Given the representation of each 
signature across the genome, there is clearly a highly significant preference for Enh and aTSS in 
the chromatin environment at Su(H) bound loci.   
 
To assess how well the chromatin signature predicted Su(H) occupancy, we considered four high 
affinity Su(H) binding-motifs and asked what proportion of these in each chromatin state were 
occupied. Of the small fraction of bound motifs in each cell type (Fig. 2A,B; 59/11,783 bound in 
BG3 cells and 89/11,783 bound in Kc cells), the majority were in Enh and aTSS states despite 
these housing a minority of the four motifs (Fig. 2B). In contrast “Basal” (black) chromatin 
contained the largest proportion of motifs (3520 motifs in BG3; 5897 motifs in Kc), yet had 
negligible binding. These data indicate that >91% of the Su(H) motifs are likely to be masked from 
binding due to the chromatin environment. Knowledge about the chromatin state in a given cell-
type can therefore help identify which motifs are more likely to be bound by Su(H), thus rendering 
the associated loci sensitive to Notch signalling. 
 
Despite the considerable gains we observed by mapping motifs onto chromatin states there 
remains a paradox, since only 40/545 Su(H) motifs present in “favoured” Enh-chromatin were 
actually occupied in BG3 cells (Fig. 2B) and only 55/529 in Kc cells (Fig. 2B). Therefore, the 
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majority of positions in the genome where the motif was in a favourable chromatin state, with 
accessible DNA and histone modifications linked to enhancer activity, were not stably bound by 
Su(H). This suggests that, while the chromatin environment is important, additional factors and/or 
as yet unknown chromatin characteristics determine where Su(H) binds.  
 
We then examined whether the chromatin signatures could account for cell-type Su(H) binding, 
focussing again on the four high affinity motifs (Fig. 2A). For motifs that were bound in both cell 
types the situation was straightforward, as 100% of those present in Enh state in one cell type 
were also in Enh state in the other (Fig. 2D, brown). These included the Notch locus, where 
binding occurred at motifs that were in favourable chromatin state in both cell-types (Fig. 2C, top). 
For those with differential binding in the two cell types, only a subset fit the predicted pattern. 
These included bigbrain (bib), where the motif was bound by Su(H) in BG3 cells and was within 
Enh (red) chromatin, but was unbound in Kc cells, where it was in basal chromatin (Fig. 2C 
middle). Likewise myc/diminutive (dm) was bound in Kc cells in the Enh (red) state, but not in BG3 
cells where it was in Comp (green) (Fig. 2C). Overall, for approximately 30-40% of bound motifs 
that were in Enh3 in one cell type, the differential binding was correlated with a change in 
chromatin state (so that it was less favourable in the cells where the motif was unbound; Fig. 2D). 
For the remainder, there was no change in the chromatin state between the cell types to account 
for the differences in occupancy as they mapped to Enh chromatin in both (Fig. 2D). Thus, while 
Enh chromatin appears conducive to Su(H) binding, this condition is not sufficient to predict that 
binding will occur.  
 
Roles of cooperating factors and Su(H) in conferring chromatin characteristics at 
enhancers 
We have previously shown that cooperating transcription factors, such as Lz/Runx, are important 
for conferring specificity to the Notch response (Terriente-Felix et al, 2013). To ask whether Lz was 
capable of generating a favourable chromatin environment, we induced elevated Lz expression in 
Kc cells, (where Lz levels are normally low (Terriente-Felix et al, 2013)) and in BG3 cells (where Lz 
was not detectably expressed) then monitored the consequences at the pebbled locus (peb). Of 
three mapped Notch-responsive enhancers in peb, two (peb3 and peb2) were in unfavourable 
chromatin states (Comp or Pc) in both cell types and exhibited no Su(H) recruitment (Fig.3A). The 
other, peb1, was in Enh state (red) in Kc cells, where low levels of Su(H) binding below the 
threshold of detection in genome-wide ChIP but apparent in specific ChIP-PCR (Fig.3B), 
correlates with a mild (5x) induction of peb in these cells (Terriente-Felix et al, 2013).  
 
Production of Lz in each cell type strongly induced the expression of peb mRNA, which was further 
enhanced by Notch activation (Fig. 3C). The changes in RNA expression correlated with de novo 
recruitment of Su(H) at peb3 and peb2 enhancers (Fig. 3B) and with an increase in Enh 
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associated histone modifications (Fig. 3D-F). Notably, H3K4me1, H3K27Ac and H3K56Ac were all 
increased at peb3 and peb2 in both cell-types. Although detectable in both, the effects of Lz were 
much greater in Kc cells than in BG3 cells, suggesting that pre-existing factors facilitate its actions. 
Furthermore, peb1 appeared the least responsive in BG3 cells, despite manifesting an active 
conformation in Kc cells. Nevertheless, the results demonstrate that Lz expression can elicit 
changes in histone modifications to convert the chromatin at two target enhancers towards the 
active Enh state, which correlates with their ability to recruit Su(H).  
 
To assess whether Lz has more widespread effects, we profiled the changes in H3K56ac following 
Lz expression in Kc cells. These results confirmed that the acetylation was increased at several 
other loci in addition to peb enhancers, with 459 regions showing significant change (1% FDR). 
Notably these included significant relationship with Notch regulated genes (Fig. 3G), as 
exemplified by peb and klu (Fig. 3H), as well as known Crystal-cell and Lz regulated genes (Fig. 
3G) such as PPO1/Bc (Fig. 3H; Ferjoux et al, 2007). Few (3%) of the changes occurred in regions 
of Enh chromatin. Around 26% mapped to Comp chromatin (as for peb) and 14% mapped to Basal 
(as for PPO1), supporting the model that Lz expression facilitates their conversion to a more active 
chromatin state. 
 
Since Su(H) is present at many enhancers in un-activated cells it could potentially also contribute 
to the chromatin landscape, as suggested by reports that the mammalian homologue acts as a 
“bookmark” remaining on chromatin at mitosis (Lake et al, 2014). To investigate this possibility, we 
analyzed the consequences of depleting Su(H) levels by RNAi treatment on Enh modifications at 
several target enhancers in BG3 cells. Under conditions where <20% Su(H) mRNA remained, 
H3K4me1 was unchanged, but both H3K27ac and H3K56ac were markedly increased (Fig. 3I). 
These changes were specifically detected at the enhancers where Su(H) was bound in BG3 cells 
(e.g. Him, bib, dpn; Fig. 3I) not at those that were unbound (e.g. peb1, peb2; Fig. 3I). Analysis of 
target gene mRNA changes under similar conditions showed that a number of these loci were de-
repressed (e.g. E(spl)mβ−HLH, bib, Table S1). This is consistent with a model where co-
repressors associated with Su(H) recruit histone deacetylases (HDACs) that are important in 
suppressing expression from target loci in the absence of Notch signalling. Thus it appears that, 
although Su(H)-bound regions exhibit characteristics of Enh chromatin, these regions often have 
lower than average levels of H3K27ac and H3K56ac due to the presence of Su(H) (Fig. E4A). This 
does not appear to be the case for all bound regions, potentially indicative of different modes of 
regulation.  
 
Changes in histone modifications following Notch activation include robust increase in 
H3K56 acetylation 
Although CSL resides at some target enhancers prior to Notch activation, several studies have 
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shown that CSL binding, as detected by ChIP, increases substantially following Notch activation 
and that CSL is detected de novo at many loci (Castel et al, 2013; Housden et al, 2013; Krejci & 
Bray, 2007; Wang et al, 2014). To address whether such de novo binding occurs at sites located in 
different chromatin contexts, we analyzed the profile of Su(H) binding 30 minutes after eliciting 
Notch activation in BG3 cells. To achieve this temporal control we used the calcium chelator EGTA, 
which disrupts the extracellular domain of Notch making it accessible to the activating proteases 
(e.g. (Ilagan et al, 2011) (Krejci & Bray, 2007) (Gupta-Rossi et al, 2001). As anticipated, a large 
increase in the number of Su(H)-bound sites was detected under these conditions (Fig. 4A; 388 
activation-only peaks). We therefore asked whether de novo bound regions differed in their 
chromatin state from those where Su(H) was detected prior to activation. This was generally not 
the case: the distribution was broadly similar to control un-stimulated cells with the majority (70%) 
of occupied sites mapping to Enh chromatin (Fig. 4B) which increased the fraction of bound high 
affinity motifs in Enh to 16% (89/545). However, for a small fraction of loci (10%) the bound regions 
occurred in the chromatin state indicative of Polycomb regulation (Pc, blue). The majority of these 
had bivalent characteristics, with low levels of enhancer-associated modifications (such as 
H3K4me1) in addition to the H3K27me3 Polycomb-related modification.   
 
 To investigate whether Notch activation could induce changes in chromatin at the regulated loci, 
we examined a wide range of histone modifications at Su(H)-bound regions before and after Notch 
activation by EGTA (Fig 4C-E). The majority of those tested were unchanged by Notch activity. 
Notable exceptions were H2B ubiquitination (H2Bub), H3K27ac and H3K56ac which all increased 
following Notch activation, while several loci showed reduced H3K4me1. Of the changes observed, 
the increase in H3K56ac was the most unexpected as this residue, located within the histone core, 
has not previously been shown to exhibit dynamic changes and has largely been linked to DNA 
replication or damage. In contrast, recent studies in mammalian cells have reported changes in 
H3K27 acetylation with longer-term differences in Notch activity. Our results indicate that both the 
H3K27ac and H3K56ac are acute effects, occurring within minutes, and are likely related to NICD 
recruitment directly. To confirm whether the increases in H3K56ac is also directly dependent on 
Notch activity, we assayed H3K56ac in the presence of a γ-secretase inhibitor (GSI) to prevent the 
presenilin-mediated release of NICD. Treating cells with GSI (10nM Compound E) was sufficient to 
block the up-regulation of target genes (Fig. 4F). The same conditions eliminated the increase in 
H3K56ac, indicating the likelihood that it is Notch dependent (Fig. 4G). Furthermore, similar 
changes were detected in cells where NICD expression was induced using an alternate strategy 
(see below).  
 
Since there have been no previous reports of dynamic changes in H3K56ac, we assayed the 
specificity of the antibody by probing a histone peptide array containing many different 
modifications (Fig. E5A). This confirmed that the antibody was specific for the H3K56ac peptide, in 
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agreement with studies in other cells (Das et al, 2014). Further confirming our observations, we 
showed that the ChIP enrichment was eliminated in the presence of competing K56Ac peptide 
(Fig. E5B). Finally, we obtained similar results using an independent antiH3K56Ac antibody (Fig. 
E5C). Taken altogether, these data support the conclusion that the levels of H3K56ac change 
substantially at target loci upon Notch activation. 
 
Increased H3K56 acetylation after Notch activation spans large domains at regulated loci 
and is associated with intergenic RNA 
To gain a more complete picture of H3K56ac changes following Notch activation we compared 
genome-wide ChIP profiles from control and Notch activated Kc and BG3 cells. This comparison 
revealed a significant increase in H3K56ac in Notch activated cells at several specific loci (e.g. Fig. 
5, Fig.6A). The majority have Su(H) bound, are known Notch targets and/or were detectably 
Notch-regulated in these cell types (Table E1). Strikingly, increased H3K56ac was not restricted to 
the locality of the Su(H)-bound enhancers but was spread across relatively broad regions. At 
E(spl)-C, the range of increased H3K56ac in BG3 cells spanned the whole locus, while the Su(H)-
binding was restricted to specific enhancers (Fig. 5). The boundaries of the H3K56ac domain 
corresponded with chromatin state boundaries and the extent of spreading was best predicted by 
the presence of H3K4me1 (Fig. E4B). For example, in Kc cells H3K56ac covered a more restricted 
portion of E(spl)-C, exhibiting little up-regulation over distal m6/m7/m8 regions where H3K4me1 
was less enriched (Fig. 5). Up-regulation of H3K56ac in Kc cells across a similar region of the 
complex was also detected following a two-hour induction of NICD under the control of a 
metallothienin promoter (Fig. 5), along with significant changes at 656 other regions that included 
peb and klu enhancers as well as other Notch-regulated genes (e.g. Table E1). The differences in 
the H3K5ac profiles over the E(spl)-C in the BG3 and Kc cell-types correlated with differences in 
responding gene activities, as more distal genes, such as E(spl)m6-BFM were poorly up-regulated 
in Kc cells (Terriente-Felix et al, 2013); Table E1).  
 
Other loci exhibited similar cell-specific broad increases in H3K56ac. At the Him locus, the increase 
in H3K56ac after Notch activation occurred only in BG3 cells, where Him is Notch-regulated, and 
encompassed the divergently transcribed Him and Her genes up to the boundaries of neighbouring 
genes (Fig. 6A). Strikingly, when the Hidden Markov Models were re-run including the profile of 
H3K56ac from Notch activated cells, the Him enhancer was reclassified as Enh (red) from Comp 
(green; Fig. 6A). Similarly, bib also exhibited an increase in H3K56ac following Notch activation in 
BG3 cells, where the modified region spread across the intronic peak of Su(H)-binding into the 
intergenic region (data not shown). Thus, not only were changes in H3K56ac detected rapidly 
after Notch activation, they also extended through large territories associated with the regulated 
loci.  
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Since H3K56 hyper-acetylation is reported to facilitate divergent transcription (Marquardt et al, 
2014) we assessed whether any intergenic transcription of non-coding RNAs was detectable within 
the E(spl)-C and whether this increased following Notch activation. Probing several of the regions 
flanking Su(H) bound enhancers we detected low levels of intergenic RNAs whose expression 
increased substantially in the Notch activated cells (Fig. 6B). This increase was attenuated when 
the cells were treated with the γ-secretase inhibitor (GSI, CompE) indicating that it was dependent 
on the activating cleavage (Fig. 6B). Thus it appears that Notch activation results in increased 
transcription of intergenic enhancer RNAs (e-RNA) as well as an increase in H3K56ac. 
 
Increased H3K56 acetylation is CBP-dependent, transcription-independent and also occurs 
at mammalian Hey1 
Assays of total levels of H3K56ac in Drosophila and mammalian cells have demonstrated that this 
modification requires CBP/p300 histone acetylases (Das et al, 2009). Since p300 is recruited to 
target loci by a complex containing NICD and Mastermind (Fryer et al, 2002; Oswald et al, 2001; 
Wallberg et al, 2002), it is a prime candidate to mediate modifications associated with Notch 
activation. To ascertain whether the single Drosophila homologue of CBP/p300 (Nejire) is 
necessary for the H3K56ac increase following Notch activation, we treated cells with C646, an 
inhibitor that is specific for the CBP HAT domain (Bowers et al, 2010). A brief 30min treatment with 
C646, which was sufficient to prevent the up-regulation of E(spl)m3-HLH and E(spl)mβ−HLH 
mRNAs (Fig. 6B,C) and of intergenic RNAs (Fig. 6B), fully suppressed the increase in H3K56ac at 
target enhancers from E(spl)-C and from other loci (Fig. 6D). A second inhibitor, curcumin, which 
inhibits CBP as well as other acetylases, similarly blocked both mRNA up-regulation and the 
increase in H3K56ac (Fig. E6A,B). Likewise, depletion of CBP in Kc cells and in vivo (using RNAi) 
led to reduced H3K56ac and compromised expression of a Notch regulated gene (cut; Fig. E6C-
F).  In contrast, neither the changes in mRNA expression nor H3K56ac levels were prevented by 
an inhibitor that interferes with another functional domain in CBP (ICG-001; Fig. E6A,B). Together 
the results from these inhibitors suggest that the change in H3K56ac following Notch activation is 
dependent on the catalytic HAT activity of CBP. 
 
When free histone dimers undergo H3K56ac modification, they are associated with the chaperones 
CAF-1 and Asf1. Under these circumstances, the bromodomain of CBP is necessary for the 
interaction with Asf-1, which brings the enzyme in proximity to its lysine substrate (Das et al, 2014). 
To investigate whether a similar mechanism could be involved at Notch regulated enhancers, we 
tested the consequences of treating cells with two CBP bromodomain inhibitors (I-CBP112, SGC-
CBP30; (Gallenkamp et al, 2014; Hay et al, 2014). Of the two, only SGC-CBP30 inhibited Notch-
dependent transcription from E(spl)-C genes at the concentrations tested, resulting in a 4-5-fold 
reduction in the induced mRNA levels and a similar reduction in the levels of intergenic RNAs (Fig. 
6B,C). Under the same conditions, SGC-CBP30 had no effect on H3K56ac levels following Notch 
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activation (Fig. 6D), suggesting that the Notch induced modification occurs independently of the 
CBP bromodomain, although the inhibitory effects on mRNA induction imply that the domain could 
have some role in Notch-regulated transcription. 
 
A second question was whether the change in H3K56ac is a consequence of increased 
transcription at the regulated loci, since the modification also occurs at TSS. To address this, cells 
were treated with DRB, a potent inhibitor of the kinase subunit in P-TEF, which prevents entry into 
transcription elongation (Marshall & Price, 1995). Despite the fact that the drug effectively 
eliminated mRNA expression from the regulated genes (Fig. 6C), and strongly reduced the up-
regulation of intergenic RNAs (Fig. 6B) it did not affect H3K56ac levels (Fig. 6D), arguing that the 
modification occurs independently of transcription elongation. Similar results were obtained with 
flavopiridol, which also blocks transcription elongation. Flavopiridol prevented mRNA up-regulation 
without affecting the increase in H3K56ac (Fig. E6). These results suggest that H3K56ac precedes 
the effects on mRNA transcription and fit with the fact that some genes with increased H3K56Ac 
were not detectably up-regulated under the conditions used (Table E1). Taken together, the results 
from the inhibitor experiments argue that H3K56ac modification in response to Notch at regulated 
loci requires CBP HAT activity but is largely independent of both mRNA and e-RNA transcription 
elongation.  
 
Finally we asked whether such changes in H3K56ac also occur at Notch-regulated enhancers in 
mammalian cells, using mouse C2C12 cells where the binding profile of mouse CSL (also known 
as RBPJ) has been described (Castel et al, 2013). Those studies revealed that binding was 
dynamic at Notch inducible enhancers, such as Hey1, and constitutive at other loci, such as 
Krt9/14, whose expression was unchanged following Notch activation (Castel et al, 2013). C2C12 
cells were exposed to the Notch ligand (Dll1) for 2.5 and 6 hours and the consequences on 
H3K56ac at the Hey1 and Krt9/14 enhancers analyzed. Hey1 was selected because the enhancer 
is well separated from the gene body (Fig. 6E) and the RNA levels were induced 3x compared to 
controls. A robust increase in H3K56ac was detected at the Hey1 enhancer, but not at the 
constitutive Krt9/14 locus where the levels of this modification were already comparatively high 
(Fig. 6F). Thus, mammalian cells exhibit an increase in H3K56ac at the Notch inducible Hey1 
enhancer, similar to that seen in Drosophila cells.  
 
Increased H3K56 acetylation also occurs in response to Ecdysone  
Since H3K56ac is detected widely at enhancer regions, the modification may be acquired in 
response to other signals besides Notch. The steroid hormone ecdysone acts through the nuclear 
ecdysone receptor (EcR; (Thummel, 1995) and, as with NICD/CSL, hormone binding converts the 
receptor from a repressing to an activating complex (Tsai et al, 1999). We therefore assessed 
whether the response to ecdysone is accompanied by a similar change in H3K56ac, using data on 
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EcR binding and EcR responsive enhancers (Gauhar et al, 2009; Shlyueva et al, 2014) to select 
appropriate regions. For example, distal ecdysone-responsive enhancers are located between Dip-
B and pri/tal (Shlyueva et al, 2014; Chanut-Delalande et al, 2014) and EcR binding to Eip78C has 
been mapped to a regulatory enhancer in a large intron (Gauhar et al, 2009; Fig. 7A). Strikingly, 
large changes in H3K56ac were detected around these target enhancers within 1 hour of ecdysone 
exposure, and remained consistent over longer periods of stimulation (Fig. 7B). Similar large-scale 
changes also occurred at Hr4 (Fig. 7C), correlating with the robust increases in RNA levels (Fig. 
7D). Rapid increases in H3K56ac are therefore a characteristic of ecdysone-activated enhancers in 
addition to those regulated by Notch. 
 
DISCUSSION 
 
Signalling pathways such as Notch have diverse functions depending on the context in which they 
are activated and on the specific subsets of genes that are regulated in each context. This 
specificity necessitates mechanisms that enable Su(H) to recognise and bind to appropriate 
enhancers and effect relevant gene expression changes. By utilizing the comprehensive collection 
of chromatin modifications gathered by the modENCODE project (Kharchenko et al, 2011), we 
have generated maps of chromatin states in two Drosophila cell-types and related those to the loci 
that are bound by Su(H). In doing so we also analyzed the profile of H3K56ac across the genome 
and found that this core histone modification is present at enhancers, and at transcription start 
sites, similar to the reported distribution in mammalian ES cells (Xie et al, 2009). Significantly, the 
inclusion of H3K56ac binding data in the computational model helped to discriminate the active 
enhancers. Even more striking, was the robust increase in this core nucleosome modification in 
response to Notch activation. Such changes were also detected in mammalian cells and at 
ecdysone regulated genes in Drosophila, arguing that H3K56ac is likely to be a widespread 
modification associated with enhancer activation.  
 
Unlike the modifications to exposed histone tails, which primarily provide docking sites for further 
chromatin modifying proteins, H3K56ac can directly alter nucleosomal DNA accessibility by 
increasing DNA breathing and unwrapping rate (Neumann et al, 2009; North et al, 2012). As a 
consequence, this modification can influence transcription factor (TF) occupancy within the 
nucleosome (Shimko et al, 2011; Tan et al, 2013) and it has been argued that H3K56ac drives 
chromatin toward the disassembled state during transcriptional activation (Williams et al, 2008). As 
the increase in H3K56ac appears to precede transcription elongation, it fits with the latter model. 
Furthermore, as mammalian CSL has been found to bind preferentially to motifs at the nucleosome 
exit point (Lake et al, 2014), H3K56ac may enhance recruitment, giving a feed-forward benefit that 
could potentially explain the increase in occupancy following Notch activation. In addition, 
H3K56ac facilitates divergent transcription by promoting rapid nucleosome turnover (Marquardt et 
al, 2014) and also promotes small RNA production in neurospora (Zhang et al, 2014), which is 
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consistent with our detection of intergenic enhancer-templated RNAs in the modified regions 
following Notch activation.  
 
The increase in H3K56ac appears to require CBP HAT activity, which is also essential for 
catalyzing this modification on free histones (Das et al, 2009). It is plausible therefore that the 
increase in H3K56ac could occur through the incorporation of premodified nucleosomes. The 
modification of histone dimers requires interaction with the chaperones CAF1 and ASF1, and while 
genetic evidence that the chaperone subunit dCAF-1-p105 can help promote Notch signalling (Yu 
et al, 2013) favours such a model, our results suggest this is less likely. First, we find that CBP is 
required at the time of activation, making it improbable that the increase in H3K56ac is a 
consequence of loading pre-modified histones. Second, an inhibitor of the CBP bromodomain, 
which plays an important role in enabling H3K56ac on histone dimers via its interaction with 
chaperones (Das et al, 2014)), had no effect on the increase in H3K56ac. Thus it seems more 
likely that the modification occurs at the time of enhancer activation, although it may nevertheless 
involve nucleosome exchange. For example SWI/SNF nucleosome remodellers have been found 
to act in combination with H3K56ac to promote nucleosome turnover and gene activity in yeasts 
(Watanabe et al, 2014; Xu et al, 2005).  At several loci where we detected changes in H3K56Ac, 
the modification extended broadly from the site of Su(H)/NICD binding, correlating with domains 
that already possessed H3K4me1. Along with data from other studies of enhancer activation (Calo 
& Wysocka, 2013; Smith & Shilatifard, 2014), and the observation that levels of H3K56ac are 
affected by mutation of H3K4 (Guan et al, 2013), this suggests that H3K4me1 is likely to be one of 
the earliest modifications, prefiguring sites of active enhancer. It may also facilitate the spread of 
H3K56ac across the regulated regions.  
 
Our analysis of the relationship between chromatin states and regions occupied by Su(H) suggests 
that the pre-existing chromatin environment is likely to make an important contribution to 
recruitment. First, Su(H)-occupied motifs were almost exclusively located in highly accessible 
chromatin, with modifications such as H3K4me1 characteristic of enhancer states. Second, 
expression of the cooperating transcription factor Lz converted enhancers towards this preferred 
chromatin state where additional Su(H) was recruited. By having a preference for a particular 
chromatin signature the vast majority (>91%) of potential Su(H) binding-motifs will be masked by 
unfavourable chromatin. Indeed the small fraction of sites that do not fit with this pattern may 
reflect false positives in the ChIP data or in chromatin assignment. The greater paradox is that only 
7-10% of CSL motifs within the favourable Enh chromatin were bound. Furthermore, many of the 
positions that were differentially bound in two cell types existed in Enh chromatin in both cell types 
examined. These observations suggest that additional factors restrict CSL binding to a subset of 
sites located within favourable chromatin. Such factors might include currently unknown histone 
modifications, protein-protein interactions, 3D organisation and/or DNA sequence properties 
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around the CSL motif.  
 
Once bound, Su(H) itself also helps to shape the local chromatin environment. Depleting cells of 
Su(H) resulted in an increase in local histone acetylation (H3K27ac, H3K56ac) suggesting that, in 
the absence of NICD, Su(H) helps to suppress enhancer activity through its association with co-
repressors. Thus a model emerges in which Su(H) is recruited to regions that have already 
acquired regulatory competence and that it keeps these in a transitional state with low levels of 
H3K56ac. As there is considerable variability between enhancers, this suggests that each attains 
an activity that reflects the balance between the transcription factors promoting enhancer activity 
and those, such as Su(H), that can antagonize it. In those instances where Su(H)-corepressor 
complexes win out, then the enhancer is suppressed until the complimentary activity of NICD 
converts it from a transitional to an active state, a conversion that is associated with a large-scale 
increase in H3K56ac.  
   
The extent that the principles we have observed here will be of general relevance for other 
signalling pathways remains to be established, although it seems likely that their target gene 
specificity will be similarly dependant on the pre-existing chromatin substrate. However, it is 
possible that the inferred transitional enhancer states may be particularly relevant for those 
pathways/contexts where there is a fine-scale switch between repression and activation, as occurs 
for Notch and ecdysone signalling. Nevertheless, the correlation of H3K56ac with H3K4me1 
suggests that H3K56ac is likely to be of widespread importance in enhancer activation. Whether 
this will be mediated through its direct effects on DNA-histone core interactions or through 
intermediate bromodomain containing proteins that link to the core transcription machinery, such 
as Brd4, remains to be determined.   
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MATERIALS AND METHODS 
 
Computational methods.  
Details of the datasets, normalization and training for the Hidden Markov Models, are provided in 
Supplementary methods along with a summary of the algorithm used to detect differences in 
H3K56ac and of motif enrichment analysis. The BED files containing the chromatin maps are 
available on GitHub at https://github.com/rstojnic/notch-chromatin as are the data and scripts used.  
 
Cell culture, Notch activation and inhibitor treatments 
Kc cells were cultured at 25 OC in Shields and Sang M3 insect medium (Sigma, S3652), 
supplemented with 5% FBS (Sigma, F9665), 1 g/L yeast extract (Oxoid, LP0021), 2.5 g/L bacto-
peptone (BD Biosciences, 211677) and 1x Antibiotic-Antimycotic (Gibco, 15240-062). BG3 cells 
were cultured at 25 OC in Shields and Sang M3 insect medium, supplemented with 10% FBS 
(Sigma, F4135), 10 mg/L insulin (Sigma, I9278), and also 1x Antibiotic-Antimycotic.For Notch 
activation, Kc cells were treated with 4mM EGTA in PBS and BG3 cells were treated with 4mM 
EGTA in HBSS (Invitrogen, 14170) for 30min unless otherwise stated. EGTA destabilizes the Notch 
negative regulatory region, exposing the site for Adam10 and consequently results in γ-secretase 
cleavage and release of NICD e.g. (Ilagan et al, 2011; Krejci & Bray, 2007; Gupta-Rossi et al, 
2001). To demonstrate Notch dependant effects of this treatment, cells were incubated with γ-
secretase inhibitor (10nm Compound E, see Table E3). Kc cells were treated with 5µM ecdysone 
(Sigma, H5142) for 1hr or 3hr before RNA or chromatin isolation. For inhibitor treatment, BG3 cells 
were pre-treated with inhibitors, as listed in Table E3, and then incubated with EGTA or HBSS plus 
inhibitors for a further 30min. Conditions for culturing and Dll1 treatment of C2C12 cells were as 
described previously (Castel et al, 2013). 1x10^6 cells were plated onto culture dishes pre-coated 
with Delta-like 1 fused to the Fc fragment of human IgG (Dll1-Fc) or with Fc fragment of human IgG 
(Control-Fc). 20µM DAPT (Calbiochem, #565784) was included in control-Fc incubations. 
 
Chromatin Immunoprecipitation , ChIP-array and RNA isolation. 
ChIP experiments, RNA isolation, real-time PCR were basically performed as described (Krejcí and 
Bray, 2007) with the following modifications. 1% formaldehyde was used for ChIP crosslinking and 
the DNA was purified after proteinase K treatment using columns (Qiagen, 28106). 6-10x106 cells 
were used as a starting material for Su(H) ChIP arrays and the resulting DNA, along with 10ng of 
input, were amplified using the WGA2 (Sigma) for two rounds of amplification (14 and 6 PCR 
cycles). For H3K56ac ChIP-arrays, 5x106 cells and 14 amplification cycles were used. All 
antibodies used for ChIP are listed in Table E4. For whole genome analysis, 1 µg double stranded 
ChIP or input DNA was labelled with either Cy3 or Cy5-random primers using the Nimblegen Dual 
Colour Kit. Both ChIP and input were co-hybridised to NimbleGen D. melanogaster ChIP-chip 2.1M 
Whole-Genome Tiling Arrays in the Nimblegen hybridisation station at 42°C for 16 hours, then 
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washed according to the NimbleGen Wash Buffer Kit instructions. The arrays were scanned at 5 
µm resolution with a GenePix 4000B (Axon) dual laser scanner at individually optimised PMT gain 
settings and images processed with NimbleScan software (Roche-Nimblegen) with Loess spatial 
correction. The data were then normalised using quantile normalisation across the replicate arrays 
in R. Window smoothing and peak calling was performed using the Bioconductor package Ringo 
(Toedling et al, 2007) with a winHalfSize of 600bp and min.probes = 5. Probe levels were then 
assigned p-values based on the normalNull method, corrected for multiple testing using the 
Hochberg-Benjamini algorithm and then condensed into regions using distCutOff of 300bp. Data 
from genome-wide ChIP experiments have been deposited in the National Center for 
Biotechnology Information Gene Expression Omnibus (GEO, www.ncbi. nlm.nih.gov/geo/) and are 
accessible through GEO Series accession number GSE66227. 
 
In RNA isolation, DNAse treatments (Ambion, AM1906) were performed before RNA reverse 
transcription. To assess non-coding/intergenic transcription, 5ug RNA was reverse transcribed with 
random primers and Superscript III. The product was then diluted 1:5 and 2μl was used in each 
real-time PCR reaction. “No reverse transcription” control was performed in parallel to confirm the 
absence of genomic DNA. All primers used in real-time PCR are listed in Table E5. 
 
Lz overexpression, NICD expression and Su(H) RNAi in cells lines 
Kc and BG3 cells were transfected with pMT-puro plasmid, pMT-puro-Lz or pMT-puro-NICD 
construct and then grown under permanent selection with 2μg/ml puromycin (Sigma). Expression 
of Lz and NICD were induced by adding 500μM CuSO4 (Sigma) to cell culture medium for 3 days 
or for 2 hours respectively. pMT-puro was a gift from D. Sabatini (Center for Cancer Research, MIT, 
Cambridge, USA), Lz cDNA plasmid was a gift from M. Haenlin (Centre de Biologie du 
Développement, Toulouse, France). For Su(H) RNAi, BG3 cells were transfected with 20ug dsRNA 
in Fugene 6 (Promega, E2691) in 10 cm plates according to the standard protocol and then 
incubated for 72h.  
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FIGURE LEGENDS 
 
Figure 1: Relationship between Su(H) binding and the chromatin state.  
(A) E(spl)-C along with the histone modification data used to generate the chromatin signatures, 
where enrichment is shaded brown (highly enriched) to blue (depleted). Su(H) binding profile for 
BG3 cells (brown graph: fold enrichment, Log2 scale is -1.2 to 3.89 and  blue shading indicates 
significant peaks 1% FDR) aligned with the chromatin map colour-coded as in B. Gene models are 
depicted in blue. (B) Summary of the 11 chromatin signatures derived from Hidden Markov model, 
showing enrichments for a subset of histone modifications, brown (highly enriched) to blue 
(depleted); see Fig. E1 for full profiles and comparisons. (C) Numbers and extent of overlap in 
Su(H) occupied regions between Kc and BG3 cells, the Su(H) motif was highly enriched in both 
data sets (p-values 4.2·10-10 and 2.12·10−14). (D) Distribution of Su(H) bound regions according to 
chromatin type in BG3 (upper) and Kc (lower) cells; chromatin is colour coded according to the 
scheme in B and Fig. E1A. Grey bars indicate the proportion of the genome in each chromatin 
signature.  
 
Figure 2: Differences in chromatin correlate with Su(H) binding at some, but not all, loci. 
(A) High affinity motifs used in the analysis and numbers occupied by Su(H) in each cell type as 
indicated. (B) Distribution of bound and unbound motifs according to chromatin type. Colour code 
indicates chromatin type, the number of motifs in each state are indicated. (C) Examples where 
Su(H) binding is concordant with chromatin. Each panel depicts a gene region with the chromatin 
map (colours as in Fig. 1B), Su(H) binding profiles for each cell type (fold enrichment Log2 with 
ranges -1.2 to 3.89 for BG3 and -0.86 to 2.09 for Kc167; significant 1% FDR peaks are shaded in 
blue) and positions of Su(H) motifs indicated. Gene models are depicted beneath each plot. (D) 
Graph summarizing the relationship between binding and chromatin in the two cell types. Brown 
bars, loci bound in both cell types; chromatin environment of bound motifs in Kc cells that were 
bound in Enh chromatin in BG3 cells. 100% are in Enh chromatin in both cell types. Green bars, 
motifs bound in Kc but not in BG3; chromatin environment of unbound motifs in BG3 cells that 
were bound in Enh chromatin in Kc cells. Blue bars, motifs bound in BG3 but not in Kc; chromatin 
environment of unbound motifs in Kc cells that were bound in Enh chromatin in BG3 cells. Some 
unbound motifs in each cell type are in less favourable chromatin but many remain in Enh even 
though not detectably bound. 
 
Figure 3: Roles of a cooperating factor and of Su(H) in conferring chromatin characteristics 
at bound enhancers 
(A) peb region with chromatin maps, Su(H) binding profiles and H3K4me1 heat maps for each cell 
type, the known Su(H)/Notch-regulated peb enhancers are indicated, along with primers used. (B) 
Fold-change in RNA levels in Kc and BG3 cells in the presence of Lz compared to control 
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conditions (con: empty pMT) and to cells with Notch activation (Nact). Lz expression was induced 
for 3 days prior to the experiment and RNA was analyzed 30 minutes after exposing cells to control 
conditions or to EGTA to elicit Notch activation. (C) Bound Su(H) was captured by ChIP from Kc 
(grey/black) and BG3 (light/dark green) cells, with (black, dark green) or without (grey, light green) 
ectopic Lz, and the levels of the indicated enhancers analyzed. Binding was significantly enriched 
at peb3 in BG3 and Kc cells and at peb2 in Kc cells (p<0.05) (D-F) Enrichment of the indicated 
histone modifications detected by ChIP in Kc (D,E) and BG3 cells (F); control cells (grey; empty 
pMT), with ectopic Lz (black). peb regions analyzed correspond to those depicted in A (primers) 
and enrichment was calculated relative to total H3. Changes in the modifications at peb3 and peb2 
were significant in all cases (p<0.05) (G-H) Differences in the profile of H3H56ac upon expression 
of Lz. (G) Percentage of regions with significant differences located in proximity to 224 
Notch/Su(H) regulated genes (green, p=1.6x10-18; Krejci et al, 2009), to 31 known crystal cell 
expressed genes (brown, p=0.00057; Ferjouz et al, 2007) and to 269 genes with defined GATA-
RUNX motif (blue, p=0.0019; Ferjoux et al, 2007). (H) Regions with significant differences detected 
at Notch regulated enhancers in peb and klu and at the Lz regulated enhancer in PPO1 (Ferjoux et 
al, 2007). Gene regions with chromatin maps showing difference in H3K56ac, regions where the 
difference is significant (1% FDR) are shaded. (I) Fold change in enrichment of the indicated 
histone modifications at enhancers following RNAi treatment to deplete Su(H) compared to control 
(GFP RNAi). Increase in H3K27ac and H3K56ac occur at mβ-1, mβ-2, m2, m3, him, bib, dpn, 
which are bound by Su(H) in BG3 cells but not at peb2, peb3 which are not bound by Su(H) in BG3 
cells. All graphs depict average results from ≥ 3 experiments, error bars are standard error of the 
mean, significance was determined by t-test for graphed results and hypergeometric test for pie 
chart.  
  
Figure 4: Changes in histone modifications after Notch activation: rapid and robust 
increase in H3K56 acetylation  
(A) Venn diagram summarizing the relationship between Su(H) bound regions in control and Notch 
activated (EGTA treated for 30 mins) cells. (B) Distribution of de novo Su(H) peaks, detectable only 
in activated cells, according to chromatin state. (C,D) Representative experiment comparing the 
enrichment of the indicated histone modifications at several loci in control and Notch activated (30 
minutes) cells. Details of loci analyzed are provided in Supplementary Material. (E) Changes in 
enrichment of the indicated modifications at selected loci 30 minutes after Notch activation 
compared to control treated cells. (F) Treatment with a γ-secretase inhibitor (GSI: 10nM Compound 
E) prevents the increase in mRNA levels in Notch activated cells. (G) Treatment with a γ-secretase 
inhibitor (GSI: 10nM Compound E, conditions as in F) prevents the increase in H3K56ac in Notch 
activated cells. Graphs in E-G depict average results from ≥ 3 experiments, error bars are standard 
error of the mean, differences were all significant (p≤0.05, t-test) 
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Figure 5: Increase in H3K56 acetylation at E(spl)-C in BG3 and Kc cells extends across the 
60kb locus 
E(spl)-C genomic region. For each cell type, the enrichment profiles for H3K56ac ChIP from control 
and Notch activated (EGTA-treated) cells are plotted in brown (Log2, scales are: -3.39-4.35 in BG3 
and -2.92-5.19 in Kc167), with the differences plotted below in dark green and the regions of 
significant difference shaded (1%FDR see Supplementary Methods).  For Kc cells, differences in 
H3K56ac in NICD expressing cells (after 2hr induction) versus controls are also plotted in the same 
way. Chromatin maps, colour coded as in Fig. 1B, Su(H) binding profiles for each cell type and 
enrichment maps for H3K4me1 from ModENCODE are shown as indicated. For BG3, Su(H) 
binding profile in Notch activated cells and the consequences on chromatin state from the changes 
in H3K56ac are also shown. For Su(H) ChIP profiles,  Log2, scales are -1.205-3.89 BG3 controls; -
1.145-4.03 BG3 Nact; -0.862-2.09 Kc controls and shaded regions indicate significant peaks (1% 
FDR). Gene models are depicted in dark blue. 
 
Figure 6: Selective increase in H3K56 acetylation is dependent on CBP HAT activity, 
independent of transcription elongation and occurs at Hey1 enhancer in mammalian cells.  
(A) Him-Her gene region, showing that Notch activity induces changes in H3K56ac in BG3 cells 
but not in Kc Cells. Graphs and details as in Fig. 5A. Nact chromatin shows the results from 
running the HMM using the data from the Notch activated BG3 cells, the Su(H) bound region has 
gained an Enh (red) signature. (B) Fold change in expression of intergenic RNAs at E(spl) locus 
after Notch treatment (30 mins EGTA) in the presence and absence of the indicated inhibitors. 
Upper panel summarizes the primers used to detect non-coding RNAs and their relationship to 
Su(H) binding profile (plotted as in Fig. 5). Graphs summarize the expression of intergenic RNAs 
and coding RNAs under the conditions indicated. (C) Effects of indicated inhibitors (see Table E2) 
on E(spl)mβ−HLH and E(spl)m3−HLH RNA levels following Notch activation. RNA levels from 
untreated (-) and Notch activated (+; EGTA-treated) cells were normalized to rp49. (D) Effects of 
the indicated inhibitors (see Table E2) on the fold-change in H3K56ac in Nact cells compared to 
control, measured by the enrichment for the indicated loci in anti-H3K56ac ChIP. (E) Hey1 locus in 
mouse cells with previously documented CSL/RBPJ and p300 profiles (Castel et al, 2013) and 
positions of primers used in D. (F) Enrichment for H3K56ac at the indicated positions relative to 
control region (Hey1-L4; Kr9/14-con) in control cells (grey; exposed to Fc and DAPT) or in Notch 
activated cells, (blue: exposed to Fc-DLL1) after 2.5hr (light shading) or 6hr (dark shading). Graphs 
in B, C, D, F depict average results from ≥ 3 experiments, error bars are standard error of the 
mean. In B and C, differences between each treatment and control condition (DMSO) were all 
significant (p<=0.05, t-test). In D, all CBP-HAT C646 values were significantly different from DMSO 
(p≤0.05, t-test) but none of those with CBP-BRM SGC or DBR were significant (p>0.05, t-test). In F 
Hey1, Pr, L2, L1 and R1 were all significantly different from control condition (p≤0.05, t-test) while 
none of the Kr9/14 levels were significantly different (p>0.05, t-test). 
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Figure 7: Changes in H3K56Ac also accompany gene activation at ecdysone-regulated loci  
(A) Eip78C and DlpB-pri/tal gene regions showing chromatin maps and H3K56ac in un-stimulated 
cells, along with positions of primers used in B. Ecdysone responsive enhancers for DlpB-pri/tal 
are those identified in S2 cells (Shlyueva et al, 2014), EcR DamID peaks, regions bound by EcR in 
Kc cells (Chanut-Delalande et al, 2014; Gauhar et al, 2009). (B) Fold-change in H3K56ac at the 
indicated regions following 1hr (grey) or 3hr (black) treatment with 20-hydroxy-ecdysone. (C) Fold 
change in H3K56ac across Hr4, under the same conditions as B. See Supplementary Methods for 
primers. (D) Fold change in RNA levels for the indicated loci following 20-hydroxy-ecdysone 
treatment as in B. Graphs in B- D depict average results from ≥ 3 experiments, error bars are 
standard error of the mean. In B, pri/tal-bef, pri/tal-1, pri/tal-2, Eip78C-EcR were significantly 
different from control treatment (p≤0.05, t-test). In C, primers 2,3,4 and 5 showed significant 
differences from controls in both conditions (p≤0.05, t-test). In D, pri/tal, Dip-B, Eip-78, Hr4 and 
Eip75 mRNA levels were significantly increased (p≤0.05, t-test). 
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